196 related articles for article (PubMed ID: 27894318)
1. Surgical treatment of recurrent urachal carcinoma with liver metastasis: a case report and literature review.
Paschke L; Juszczak M; Slupski M
World J Surg Oncol; 2016 Nov; 14(1):296. PubMed ID: 27894318
[TBL] [Abstract][Full Text] [Related]
2. Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature review.
Miyata Y; Sagara Y; Matsuo T; Ohba K; Takahashi H; Sakai H; Kanetake H
Anticancer Res; 2011 Jun; 31(6):2335-8. PubMed ID: 21737660
[TBL] [Abstract][Full Text] [Related]
3. Urachal carcinoma: A case of a rare neoplasm.
Moreira I; Coelho S; Rodrigues Â; Patrão AS; Maurício MJ
Curr Probl Cancer; 2021 Dec; 45(6):100711. PubMed ID: 33541722
[TBL] [Abstract][Full Text] [Related]
4. Surgical and chemotherapeutic experience regarding a urachal carcinoma with repeated relapse: case report and literature review.
Zong L; Chen P
World J Surg Oncol; 2013 Aug; 11():170. PubMed ID: 23914849
[TBL] [Abstract][Full Text] [Related]
5. Surgical and chemotherapeutic options for urachal carcinoma: report of ten cases and literature review.
Yazawa S; Kikuchi E; Takeda T; Matsumoto K; Miyajima A; Nakagawa K; Oya M
Urol Int; 2012; 88(2):209-14. PubMed ID: 22143067
[TBL] [Abstract][Full Text] [Related]
6. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 14 cases of urachal carcinoma].
Chen ZF; Wang F; Qin ZK; Dai YP; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Ye YL
Ai Zheng; 2008 Sep; 27(9):966-9. PubMed ID: 18799037
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine small-cell bladder cancer: our experience].
Ruoppolo M; Pezzica E; Milesi R; Corti D; Mercurio P; Fragapane G
Urologia; 2010; 77 Suppl 17():64-71. PubMed ID: 21308678
[TBL] [Abstract][Full Text] [Related]
9. Treatment of metastatic urachal carcinoma in an elderly woman.
Mohile SG; Schleicher L; Petrylak DP
Nat Clin Pract Oncol; 2008 Jan; 5(1):55-8. PubMed ID: 18097457
[TBL] [Abstract][Full Text] [Related]
10. Urachal carcinoma: surgical and chemotherapeutic options.
Siefker-Radtke A
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1715-21. PubMed ID: 17181485
[TBL] [Abstract][Full Text] [Related]
11. Combined systemic therapy and radiotherapy for bladder cancer.
Rödel C; Weiss C; Sauer R
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():29-31. PubMed ID: 18167005
[No Abstract] [Full Text] [Related]
12. [A Case of Urachal Carcinoma Treated by TS-1/CDDP as Adjuvant Chemotherapy].
Inoue K; Shimada M; Saito K; Ogawa Y; Matsubara E; Matsumoto Y; Keiichiro H
Hinyokika Kiyo; 2015 Nov; 61(11):441-3. PubMed ID: 26699888
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy for primary adenocarcinomas of the urinary bladder: a single-site experience.
Yu B; Zhou J; Cai H; Xu T; Xu Z; Zou Q; Gu M
BMC Urol; 2015 Jan; 15(1):3. PubMed ID: 25631709
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACaG) in patients with locally advanced carcinoma of the bladder.
Grivas PD; Hussain M; Hafez K; Daignault-Newton S; Wood D; Lee CT; Weizer A; Montie JE; Hollenbeck B; Montgomery JS; Alva A; Smith DC
Urology; 2013 Jul; 82(1):111-7. PubMed ID: 23706253
[TBL] [Abstract][Full Text] [Related]
15. USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer.
Liew MS; Azad A; Tafreshi A; Eapen R; Bolton D; Davis ID; Sengupta S
BJU Int; 2013 Nov; 112 Suppl 2():74-82. PubMed ID: 24127680
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival following hepatectomy, radiation, and chemotherapy for recurrent pancreatic carcinoma: a case report.
Fujisaki S; Takashina M; Tomita R; Sakurai K; Takayama T
World J Surg Oncol; 2017 Aug; 15(1):157. PubMed ID: 28835248
[TBL] [Abstract][Full Text] [Related]
17. [Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma].
Inoue T; Ohyama C; Horikawa Y; Togashi H; Matsuura S; Tsuchiya N; Satoh S; Sato K; Habuchi T; Saito S; Hoshi S; Arai Y; Kato T
Hinyokika Kiyo; 2004 Apr; 50(4):273-7. PubMed ID: 15188623
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study.
Halim A; Abotouk N
Asia Pac J Clin Oncol; 2013 Mar; 9(1):60-5. PubMed ID: 22897883
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of paclitaxel and carboplatin as second-line chemotherapy for advanced urothelial carcinoma resistant to first-line therapy with gemcitabine and cisplatin.
Terakawa T; Miyake H; Yokoyama N; Miyazaki A; Tanaka H; Inoue T; Fujisawa M
Urol Int; 2014; 92(2):180-5. PubMed ID: 24246751
[TBL] [Abstract][Full Text] [Related]
20. [COMPLETE RESECTION OF URACHAL CARCINOMA WITH SIGMOID COLON INVASION AFTER FOLFOX CHEMOTHERAPY: A CASE REPORT].
Ito A; Takata R; Matsuo T; Kimura T; Otsuka K; Ishii S; Tokiwa S; Tanji S; Sugimura J; Omori S; Obara W
Nihon Hinyokika Gakkai Zasshi; 2018; 109(1):35-39. PubMed ID: 30662050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
